-
Important message about the impact of the coronavirus pandemic on the Society's activities. Read more
-
An update on the impact of the novel coronavirus (COVID-19) outbreak on Society meetings and events. Read more
Latest Society reponses to wider developments
-
The Society has responded to the announcement that Gilead Sciences will initiate two phase 3 randomised studies to evaluate the safety and antiviral activity of remdesivir in participants with moderate to severe COVID-19. Read more here
-
The British Pharmacological Society has responded to concerns that the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, could make the symptoms of the novel coronavirus infection, COVID-19, worse. Read more here
-
Our Journals latest news: latest news on social media
-
An update on medical school final examinations from the Medical Schools Council.
Read more
-
PSA 2020 delivery during COVID-19 pandemic: The Medical Schools Council (MSC) and British Pharmacological Society (BPS) would like to thank all medical school staff and students for their patience whilst awaiting news about the delivery of the Prescribing Safety Assessment (PSA) 2020 diet during the COVID-19 pandemic. Read more here